InsiderClue
Insiders · Profile

TOMSICEK MICHAEL JOHN

Director at Milestone Pharmaceuticals · Chief Financial Officer at CRISPR Therapeutics. Filing since 3 Aug 2020. CIK 0001570392

MIST Milestone Pharmaceuticals Inc. Director · 1 trade CRSP CRISPR Therapeutics AG Chief Financial Officer · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
MIST Milestone Pharmaceuticals Inc.
19 Oct 2022
Director
Bought
15,000
$79.80K
opened
CRSP CRISPR Therapeutics AG
6 Aug 2021
Chief Financial Officer
Sold, plan not stated
25,000
$3.46M
93.0%
CRSP CRISPR Therapeutics AG
1 Sep 2020
Chief Financial Officer
Sold, plan not stated
12,000
$1.11M
96.7%
CRSP CRISPR Therapeutics AG
3 Aug 2020
Chief Financial Officer
Sold, plan not stated
12,000
$1.04M
96.7%
4 decisions on file.